{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-282425","form_type":"8-K","ticker":"AVD","cik":"0000005981","company_name":"AMERICAN VANGUARD CORP","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.252222+00:00","generated_at":"2026-06-22T00:13:49.989427+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"American Vanguard Q3 EPS $0.23 (+27.8% YoY); adj. EBITDA view ~$80M","bullets":["Q3 net sales $152M (+3.4% YoY), net income $6.7M (+21.8%), diluted EPS $0.23.","Nine-month net sales $450M (+13.1%), net income $23.5M (+71.5%), EPS $0.78.","Full-year adj. EBITDA target ~$80M (13% of expected sales), exceeding prior 24-28% growth range.","Repurchased 1.5M shares YTD via ASR and 10b5-1 plan.","Secured Counter nematicide registration for soybeans in Brazil; alliance with NewLeaf Symbiotics."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-282425","json":"https://secwatch.observer/filing/0001193125-22-282425.json","markdown":"https://secwatch.observer/filing/0001193125-22-282425.md","text":"https://secwatch.observer/filing/0001193125-22-282425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/5981/000119312522282425/0001193125-22-282425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/5981/000119312522282425/d125853d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T00:13:49.989427+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"536582eccc5d0b41557753f96230c13e0f9a68e8","claim":"AMERICAN VANGUARD CORP reported preliminary financial results for the three- and nine-month periods ended September 30, 2022.","evidence_excerpt":"On November 8, 2022, American Vanguard Corporation (“Registrant”) issued a press release announcing its preliminary, unaudited financial results for the three- and nine-month periods ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/5981/000119312522282425/0001193125-22-282425-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three- and nine-month periods ended September 30, 2022"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}